Search for content and authors
 

The antibiotic kasugamycin mimics mRNA nucleotides to destabilize tRNA binding and inhibit canonical translation initiation

Witold Szaflarski 1Frank Schluenzen 1Chie Takemoto 2Daniel N. Wilson 1Tatsuya Kaminishi 2Joerg M. Harms 1Kyoko Hanawa-Suetsugu 2Masahito Kawazoe 2Mikako Shirouzu 2Knud H. Nierhaus 1Shigeyuki Yokoyama 2,3Paola Fucini 1

1. Max-Planck-Institute for Molecular Genetics, Ihnestrasse 63-73, Berlin 14-195, Germany
2. RIKEN Genomic Sciences Center, 1-7-22 Suehiro-cho, Tsurumi, Yokohama 230-0045, Japan
3. Department of Biophysics and Biochemistry, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan

Abstract

Kasugamycin (Ksg) specifically inhibits translation initiation of canonical but not of leaderless messenger RNAs. Ksg inhibition is thought to occur by direct competition with initiator transfer RNA. The 3.35-Å structure of Ksg bound to the 30S ribosomal subunit presented here provides a structural description of two Ksg-binding sites as well as a basis for understanding Ksg resistance. Notably, neither binding position overlaps with P-site tRNA; instead, Ksg mimics codon nucleotides at the P and E sites by binding within the path of the mRNA. Coupled with biochemical experiments, our results suggest that Ksg indirectly inhibits P-site tRNA binding through perturbation of the mRNA-tRNA codon-anticodon interaction during 30S canonical initiation. In contrast, for 70S-type initiation on leaderless mRNA, the overlap between mRNA and Ksg is reduced and the binding of tRNA is further stabilized by the presence of the 50S subunit, minimizing Ksg efficacy.

 

Legal notice
  • Legal notice:
 

Presentation: Wykład at Zjazd Polskiego Towarzystwa Biochemicznego, Sympozjum K, by Witold Szaflarski
See On-line Journal of Zjazd Polskiego Towarzystwa Biochemicznego

Submitted: 2007-04-30 21:15
Revised:   2009-06-07 00:44